Nature Research Round Table: hPSC Lines for Cell Therapies - Panel Discussion
In this panel discussion led by Dr. Christine Mummery from the Leiden University Medical Center, keynote speakers respond to questions from the forum and evaluate consensuses around topics raised in the previous talks.
This panel discussion was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
This panel discussion was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Publish Date: November 01, 2019
Views: 0
Related Multimedia
-
19:35Nature Research Round Table: Retinal Cell Therapy Using Human Embryonic Stem Cells
Publish Date: November 01, 2019 -
24:46Nature Research Round Table: Parkinson's Disease Therapy with Human Embryonic Stem Cells
Publish Date: November 01, 2019 -
17:30Nature Research Round Table: Human Pluripotent Stem Cell Lines as Disease Models
Publish Date: November 01, 2019
Explore Our Products
-
cGMP, feeder-free maintenance medium for human ES and iPS cells -
qPCR analysis kit for detecting the majority of karyotypic abnormalities reported in human ES and iPS cells -
Animal component-free suspension culture medium for human ES and iPS cells -
Animal origin-free, stabilized, feeder-free maintenance medium for human ES and iPS cells